Efficacy and Safety of Combination Comprising Tamsulosin and PDE5-Is, Relative to Monotherapies, in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction Associated With Benign Prostatic Hyperplasia: A Meta-Analysis
Authors:
Open Access
- 1 January 2021
- journal article
- letter
- Published by SAGE Publications in American Journal of Men's Health
- Vol. 15 (1)
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Efficacy and Safety of Combination Comprising Tamsulosin and PDE5-Is, Relative to Monotherapies, in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction Associated With Benign Prostatic Hyperplasia: A Meta-AnalysisAmerican Journal of Men's Health, 2020
- Tamsulosin and placebo vs tamsulosin and tadalafil in male lower urinary tract symptoms: a double‐blinded, randomised controlled trialBJU International, 2020
- Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational TrialJournal of Clinical Medicine, 2019
- Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trialArab Journal of Urology, 2016
- Comparing Monotherapy with Tadalafil or Tamsulosin and Their Combination Therapy in Men with Benign Prostatic Hyperplasia: A Randomized Clinical Trial.2016
- A Comparative Randomized Prospective Study to Evaluate Efficacy and Safety of Combination of Tamsulosin and Tadalafil vs. Tamsulosin or Tadalafil Alone in Patients with Lower Urinary Tract Symptoms due to Benign Prostatic HyperplasiaThe Journal of Sexual Medicine, 2014
- Comparative Efficacy Assessment of Tamsulosin vs. Tamsulosin Plus Tadalafil in the Treatment of LUTS/BPH. Pilot StudyThe Journal of Sexual Medicine, 2008